Rankings
▼
Calendar
CRMD Q3 2016 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$529M
Q3 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$44,451
Gross Profit
$529
1.2% margin
Operating Income
-$9M
-20602.4% margin
Net Income
-$9M
-20530.9% margin
EPS (Diluted)
$-1.17
QoQ Revenue Growth
+169.2%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$192,684
Balance Sheet
Total Assets
$29M
Total Liabilities
$5M
Stockholders' Equity
$24M
Cash & Equivalents
$10M
← FY 2016
All Quarters
Q4 2016 →
